Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitors is a research paper published in Journal for ImmunoTherapy of Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R21 CA191522
NIH
Grant: P50 CA121973; R01 CA204419; R21 CA191522
NCI NIH HHS
Grant: P30 CA047904
NCI NIH HHS
Grant: R01 CA204419
NCI NIH HHS
Grant: P50 CA121973
National Institutes of Health
Grant: 1R21CA191522-01A1
Tumor Cell-derived HMGB1-initiated Activation of Treg
National Institutes of Health
Grant: 5P50CA121973-03
Therapuetic Immune Targeting of EphA2 Expressed by Melanoma &Its Tumor-Associate
National Institutes of Health
Grant: 5R01CA204419-04
Induction of Therapeutic Immunity in the Tumor Microenvironment
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals